SCLP.GB
Scancell Holdings Plc
Main
ISIN
GB00B63D3314
Bid
9.50
Mid
10.25
Ask
11.00
Key Information
- Price Change
- 0.00%
- Year High
- 11.75
- Year Low
- 7.20
- Last Trade
- 4 Dec 25
- Market Cap
- £0.00
- Par
- 0.00
- Bid
- 9.50
- Mid Price
- 10.25
- Ask
- 11.00
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 0.000
- Sector
- n/a
Prices in GBX except for Market Cap in GBP
About Scancell Holdings Plc
Scancell Holdings plc is the parent company of Scancell Limited and acts purely as a holding company. Scancell is developing a pipeline of cancer vaccines based on its patented ImmunoBody (TM) platform which has the potential to overcome the significant limitations of existing approaches. Scancell also has the potential to generate significant revenues from licensing the technology on a target by target basis to other companies involved in the discovery and development of therapeutic vaccines. With outstanding 'proof of concept' in vivo data in place, the Company wants to take the lead melanoma vaccine, SCIB1, through a Phase I/IIa clinical trial with completion in 2012.
Today's Trading
| Volume | Total Trades | Total Trade Value (GBP) |
|---|---|---|
| 0 | 0 | 0.00 |
Latest Trades
| Date | Volume | Price (GBX) | Value (GBP) |
|---|---|---|---|
04 Dec 25 10:25 | 10,000 | 9.99 | 998.50 |
04 Dec 25 09:32 | 4,957 | 9.99 | 494.96 |
04 Dec 25 09:16 | 3,004 | 9.99 | 299.95 |
03 Dec 25 09:29 | 5,106 | 9.72 | 496.30 |
03 Dec 25 09:23 | 10,000 | 9.72 | 972.00 |
Latest Announcements & Notices
| Date | Title |
|---|---|
| No announcements or notices | |
Address
Registered Address
Phone
0115 823 1863
Contacts
Corporate Adviser
Registrar
SLC Registrars, P.O. Box 5222, Lancing, BN99 9FG, United Kingdom
